{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:51:20Z","timestamp":1772121080666,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T00:00:00Z","timestamp":1498262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jmii.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T16:31:43Z","timestamp":1498667503000},"page":"636-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["In\u00a0vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates"],"prefix":"10.1016","volume":"51","author":[{"given":"Chen-Cheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2017.05.001_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2017.05.001_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.rmed.2006.04.002","article-title":"A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease","volume":"101","author":"Kobashi","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.jmii.2017.05.001_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1378\/chest.115.4.1033","article-title":"Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without pre-existing lung disease: diagnostic and management limitations","volume":"115","author":"Huang","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2017.05.001_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1378\/chest.126.2.566","article-title":"Mycobacterium avium complex pulmonary disease in patients without HIV infection","volume":"126","author":"Field","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2017.05.001_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0732-8893(92)90044-T","article-title":"CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum","volume":"15","author":"Barrett","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2017.05.001_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/AAC.32.8.1131","article-title":"MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven anti-tuberculosis drugs","volume":"32","author":"Heifets","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.33.8.1298","article-title":"Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis","volume":"33","author":"Heifets","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/BF01992173","article-title":"Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms","volume":"12","author":"Rastogi","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2017.05.001_bib9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/AAC.39.3.638","article-title":"French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex","volume":"39","author":"Rastogi","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib10","first-page":"489","article-title":"In\u00a0vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs","volume":"66","author":"Tomioka","year":"1991","journal-title":"Kekkaku"},{"key":"10.1016\/j.jmii.2017.05.001_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0255-0857(21)02168-X","article-title":"Drug resistance profile of human Mycobacterium avium complex strains from India","volume":"25","author":"Venugopal","year":"2007","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jmii.2017.05.001_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/jcm.31.2.175-178.1993","article-title":"Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis","volume":"31","author":"Telenti","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2017.05.001_bib13","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1128\/JCM.42.3.1308-1312.2004","article-title":"Differential identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria by duplex PCR assay using the RNA polymerase gene (rpoB)","volume":"42","author":"Kim","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2017.05.001_bib14","series-title":"Susceptibility testing of mycobacteria, nocardiae and other aerobic actinomycetes","author":"Wayne","year":"2011"},{"key":"10.1016\/j.jmii.2017.05.001_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/jcm.24.6.976-981.1986","article-title":"Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth","volume":"24","author":"Wallace","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2017.05.001_bib16","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.36.9.1987","article-title":"Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system","volume":"36","author":"Brown","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib17","first-page":"580","article-title":"Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs","volume":"2","author":"Abate","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jmii.2017.05.001_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/49.2.275","article-title":"Activity of a new class of isonicotinoyl hydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis","volume":"49","author":"De Logu","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the checkerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.201307-231OC","article-title":"Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease","volume":"11","author":"Olivier","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"Suppl. 2","key":"10.1016\/j.jmii.2017.05.001_bib21","first-page":"87","article-title":"An overview of the safety of isepamicin in adults","volume":"7","author":"Blum","year":"1995","journal-title":"J Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00003088-200038030-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of isepamicin","volume":"38","author":"Tod","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jmii.2017.05.001_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1248\/yakushi.128.451","article-title":"Clinical efficacy of kanamycin for Mycobacterium avium complex disease","volume":"128","author":"Suzuki","year":"2008","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jmii.2017.05.001_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0076-6879(06)15012-0","article-title":"Molecular contacts between antibiotics and the 30S ribosomal particle","volume":"415","author":"Wirmer","year":"2006","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jmii.2017.05.001_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/CMR.05030-11","article-title":"Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria","volume":"25","author":"Brown-Elliott","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2017.05.001_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1128\/jb.110.3.978-987.1972","article-title":"Mechanism of d-cycloserine action: alanine racemase from Escherichia coli W","volume":"110","author":"Lambert","year":"1972","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jmii.2017.05.001_bib27","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/ml400349n","article-title":"Metabolomics reveal d-Alanine:d-Alanine ligase as the target of d-cycloserine in Mycobacterium tuberculosis","volume":"4","author":"Prosser","year":"2013","journal-title":"ACS Med Chem Lett"},{"issue":"5","key":"10.1016\/j.jmii.2017.05.001_bib28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.3548","article-title":"Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance","volume":"48","author":"Desjardins","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmii.2017.05.001_bib29","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.124.4.1482","article-title":"Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine","volume":"124","author":"Field","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2017.05.001_bib30","first-page":"462","article-title":"Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections \u00e0 Mycobact\u00e9ries","volume":"2","author":"Roussel","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.jmii.2017.05.001_bib31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jac\/dkw426","article-title":"Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline","volume":"72","author":"Cholo","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.00142914","article-title":"A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment","volume":"45","author":"Somoskovi","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2017.05.001_bib33","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib34","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/jac\/dkv150","article-title":"Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis","volume":"70","author":"Zhang","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib35","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.01551-06","article-title":"In\u00a0vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan","volume":"51","author":"Shen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib36","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.42.5.1295","article-title":"Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis","volume":"42","author":"Alangaden","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib37","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1128\/AAC.00851-09","article-title":"High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene","volume":"53","author":"Jugheli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib38","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2009.12.008","article-title":"High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria","volume":"35","author":"Shen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2017.05.001_bib39","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/AAC.01505-12","article-title":"In\u00a0vitro synergy between clofazimine and amikacin in treatment of non-tuberculous mycobacterial disease","volume":"56","author":"van Ingen","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.05.001_bib40","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jmm.0.45965-0","article-title":"Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates","volume":"54","author":"da Silva Telles","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jmii.2017.05.001_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijantimicag.2013.03.010","article-title":"Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance","volume":"42","author":"van Ingen","year":"2013","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217300816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217300816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:23:16Z","timestamp":1761657796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118217300816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1684118217300816"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2017.05.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.728013647.793565562","asserted-by":"object"}]},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}